AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from the ...

Commercial reprints are an excellent way for companies to promote and inform the medical community about their activities and products. They are recognized as a credible and timely source of ...